The economic burden of localized prostate cancer and insights derived from cost-effectiveness studies of the different treatments

Ver/Abrir
Identificadores
URI: https://hdl.handle.net/10902/28278
ISSN: 2072-6694
Compartir
Estadísticas
Ver Estadísticas
Google Scholar
Registro completo
Mostrar el registro completo DC
Autoría
Cantarero Prieto, DavidAutoridad Unican; Lera Torres, Javier IsaacAutoridad Unican; Lanza León, PalomaAutoridad Unican; Barreda Gutiérrez, MarinaAutoridad Unican; Guillem Porta, Vicente; Castelo Branco, Luis; Martín Moreno, José María
Fecha
2022-08-24
Derechos
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution(CC BY) license.
Publicado en
Cancers, 2020, 14(17), 4088
Editorial
MDPI
Enlace a la publicación
Palabras clave
Economic burden
Cost of illness
Cost-effectiveness analysis
Localized prostate cancer
Resumen/Abstract
Prostate cancer is one of the most frequent and impacting malignant neoplasms for men. In particular, localized prostate cancer has a notably high incidence and prevalence, despite which a solid consensus on treatment and procedure of care has not yet been reached. This article aims to shed light on this challenge by characterizing the economic burden and cost-effectiveness of different treatment strategies for localized prostate cancer after analyzing published comparable data from studies conducted in OECD countries.
Colecciones a las que pertenece
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution(CC BY) license.Excepto si se señala otra cosa, la licencia del ítem se describe como © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution(CC BY) license.